These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11323746)

  • 1. The extracellular matrix in multiple sclerosis: an update.
    Sobel RA
    Braz J Med Biol Res; 2001 May; 34(5):603-9. PubMed ID: 11323746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.
    Sobel RA; Ahmed AS
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1198-207. PubMed ID: 11764092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).
    de Jong JM; Wang P; Oomkens M; Baron W
    J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular matrix in multiple sclerosis lesions.
    Sobel RA
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):205-17. PubMed ID: 9600212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
    Maeda A; Sobel RA
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perineuronal and perisynaptic extracellular matrix in the human spinal cord.
    Jäger C; Lendvai D; Seeger G; Brückner G; Matthews RT; Arendt T; Alpár A; Morawski M
    Neuroscience; 2013 May; 238():168-84. PubMed ID: 23428622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L
    N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter involvement after TBI: Clues to axon and myelin repair capacity.
    Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM
    Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of the brain extracellular matrix: a new target for remyelination.
    Lau LW; Cua R; Keough MB; Haylock-Jacobs S; Yong VW
    Nat Rev Neurosci; 2013 Oct; 14(10):722-9. PubMed ID: 23985834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA; Blakemore WF
    Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling.
    Gutowski NJ; Newcombe J; Cuzner ML
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):207-14. PubMed ID: 10417662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions.
    Vos CM; van Haastert ES; de Groot CJ; van der Valk P; de Vries HE
    J Neuroimmunol; 2003 May; 138(1-2):106-14. PubMed ID: 12742660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
    van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Ghorbani S; Yong VW
    Brain; 2021 Aug; 144(7):1958-1973. PubMed ID: 33889940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.